Select Bibliography

Filter by any of these (after searching):

Damon, Lloyd E.

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 4 items

Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909

Damon, Lloyd E. , Johnson, Jeffrey L. , Niedzwiecki, Donna ... - - J Clin Oncol - 2009

Manuscript - Primary - Primary - Lymphoma - CALGB-59909

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

Hsi, Eric D. , Jung, Sin-Ho , Lai, Raymond , Johnson, Jeffrey L. ... - - Leuk Lymphoma - 2008

Manuscript - Secondary-not-in-original - Primary - Lymphoma - CALGB-59909

Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909

Liu, Hongtao , Johnson, Jeffrey L. , Koval, Greg , Malnassy, Greg ... - - Haematologica - 2012

Manuscript - Secondary - Primary - Lymphoma - CALGB-59909

Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance)

Malnassy, Greg , Geyer, Susan , Fulton, Noreen , Koval, Greg ... - ASH - Blood - 2013

Abstract - Secondary-not-in-original - Meta-Analysis - Leuk Corr Sci - CALGB-10403 , CALGB-59909